COMMON MAPS
Map version new-york activity top-down
MCP Main site Contact
Menu
5 ORGS · 16 ACTIVITIES ← all strategies ·
approach

Knowledge Empowerment

By disseminating credible, accessible information to patients, families, and professionals, improve health outcomes and accelerate care, because informed stakeholders make better, faster decisions in diagnosis, treatment, and research engagement. This strategy centers on closing knowledge gaps in rare disease ecosystems by actively empowering all stakeholders—especially patients and clinicians—with up-to-date, evidence-based information. Unlike research-first or funding-centric approaches, Knowledge Empowerment treats information equity as a foundational lever for systemic change, enabling earlier diagnoses, more effective advocacy, and improved clinical decisions. It is distinct from peer support or research funding strategies, though it often complements them by increasing the impact of shared knowledge and collective action.

5
orgs running it
16
activities of those orgs
8
activity groups touched
who runs it

Organizations running this strategy · 5

what it looks like in practice

Activities of orgs running this strategy

A sample of programmatic activities from the orgs above — what the strategy looks like on the ground.

  • Hosting educational webinars and virtual events CARCINOID CANCER FOUNDATION
    direct service
    Organizes monthly virtual webinars and other educational events to engage and inform neuroendocrine cancer patients about current topics in care and research.
  • Providing educational resources for neuroendocrine cancer patients and caregivers CARCINOID CANCER FOUNDATION
    direct service
    Offers comprehensive information on diagnosis, treatment options, and research for patients and caregivers, including over 550 educational videos and the NET VITALS guide for newly diagnosed individuals.
  • Supporting research on carcinoid and neuroendocrine tumors CARCINOID CANCER FOUNDATION
    research
    Encourages and funds research initiatives focused on carcinoid and neuroendocrine tumors, advancing scientific understanding and treatment development.
  • Hosting discussion forums THE VIRTUAL CENTER FOR VELO-CARDIO- FACIAL SYNDROME INC
    direct service
    Hosts a forum for discussion on problems, treatments, and recent advancements related to velo-cardio-facial syndrome, craniofacial disorders, genetic syndromes, and their management.
  • Providing free consultation and information services THE VIRTUAL CENTER FOR VELO-CARDIO- FACIAL SYNDROME INC
    direct service
    Offers free consultation and information to families and clinicians about velo-cardio-facial syndrome, craniofacial disorders, and genetic syndromes, including updates on research and treatment outcomes.
  • Organizing patient and professional educational conferences and communications The Oxalosis & Hyperoxaluria Foundation
    direct service
    Plans and conducts educational conferences for patients and healthcare professionals, distributes newsletters and mailings, and organizes medical advisory board conferences to support knowledge sharing in the oxalosis and hyperoxaluria community.
  • Conducting education and awareness activities for patients, healthcare professionals, and the public VEXAS Foundation Inc
    direct service
    Provides education and awareness about VEXAS syndrome to patients, families, healthcare professionals, and the general public through resource materials and direct information sharing. Created the VEXAS Syndrome Resource Guide in 2025 to support understanding of the condition and available treatments.
  • Funding research on VEXAS syndrome through scientific grants VEXAS Foundation Inc
    grantmaking
    Awards grants to support groundbreaking research on VEXAS syndrome, including studies aimed at understanding genetic mechanisms, developing novel treatments, and improving patient outcomes. Specifically funds research at the David Beck Lab at NYU Grossman School of Medicine.
  • Supporting and disseminating VEXAS syndrome research VEXAS Foundation Inc
    research
    Conducts, supports, and shares scientific research on VEXAS syndrome, including publishing patient-reported data from the VEXAS Patient Experience Survey and providing access to updates on research advances and treatment options.
  • Advocates for patient perspectives in regulatory review processes GALACTOSEMIA FOUNDATION
    advocacy
    Engages in advocacy to ensure patient voices are included in regulatory evaluations, such as the FDA's review of govorestat (AT-007), a potential first treatment for galactosemia.
  • Disseminates disease-specific medical information to patients and families GALACTOSEMIA FOUNDATION
    direct service
    Provides comprehensive information about galactosemia, including associated complications such as cataracts, speech disorders (e.g., apraxia), and primary ovarian insufficiency, to help families manage health outcomes and coordinate care.
  • Funds medical and scientific research on galactosemia GALACTOSEMIA FOUNDATION
    grantmaking
    Provides research grants to medical professionals and research institutions to support studies on galactosemia, including topics such as nutrition, diet, therapy, neurological deficits, and premature ovarian failure.
  • Organizes biennial conferences for the galactosemia community GALACTOSEMIA FOUNDATION
    direct service
    Hosts a biennial conference for individuals affected by galactosemia, medical professionals, and researchers to provide education, support, and advocacy. The next conference is scheduled for July 16–18, 2026.
  • Provides educational resources and support for newly diagnosed families GALACTOSEMIA FOUNDATION
    direct service
    Offers an informational toolkit and outreach program for families newly diagnosed with galactosemia, providing tools, resources, and connections to clinicians and researchers to support early education and care planning.
  • Publishes the Galactosemia Gazette newsletter GALACTOSEMIA FOUNDATION
    direct service
    Produces and publishes the Galactosemia Gazette, an online newsletter released twice annually, to share updates, research, and community news with the galactosemia community.
  • Supports individual fundraising initiatives for galactosemia GALACTOSEMIA FOUNDATION
    capacity building
    Provides capacity-building support and promotional resources to individuals and groups organizing fundraisers for galactosemia-related causes, helping to amplify community-driven funding efforts.